Novel Therapeutic Approaches to Multiple Sclerosis: Neuroprotective Drugs for Relapsing-Remitting Multiple Sclerosis
Marco Pugliese, Juan F. Espinosa‐Parrilla, Javier A. Bustos, Clara Campàs, Mercè de Frías, Georgina Sorrosal
Abstract
Marco Pugliese, Juan F. Espinosa‐Parrilla, Javier A. Bustos, Clara Campàs, Mercè de Frías, Georgina Sorrosal
Abstract
Multiple sclerosis (MS) is a chronic inflammatory and degenerative disease of the central nervous system (CNS) that causes significant disability. Immunosuppressive and immunomodulatory drugs have been designed for years to treat MS, as it was consid
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Multiple sclerosis (MS) is a chronic inflammatory and degenerative disease of the central nervous system (CNS) that causes significant disability. Immunosuppressive and immunomodulatory drugs have been designed for years to treat MS, as it was consid
Key concepts: Relapsing remitting, Multiple sclerosis, Medicine, Neuroprotection, Pharmacology, Immunology